| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.11 | 0.05 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.06 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.06 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | -0.068 | 0.06 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.06 |
| mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.06 |
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.06 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.091 | 0.06 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.06 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.071 | 0.07 |